Motley Fool  Mar 21  Comment 
The potential to leap from clinical-stage to commercial-stage biotech makes this my top pick right now.
Benzinga  Mar 14  Comment 
Bluebird bio Inc (NASDAQ: BLUE), a clinical-stage biotechnology company that focuses on therapies for the treatment of severe diseases and cancer, released "highly encouraging" clinical data in late 2017, according to Janney. But that doesn't mean...
Motley Fool  Feb 22  Comment 
The gene therapy company is on the precipice of applying for approval for its first drug.
Motley Fool  Feb 6  Comment 
The company's progress toward becoming a commercial-stage gene-therapy company is sparking optimism.
Benzinga  Jan 25  Comment 
Shares of bluebird bio Inc (NASDAQ: BLUE) are up 360 percent over the last two years, but Leerink said the stock’s losing steam. The Rating Leerink analyst Michael Schmidt downgraded Bluebird from Outperform to Market Perform and increased...
Motley Fool  Jan 22  Comment 
A big acquisition is sparking interest in the gene therapy company.
Motley Fool  Jan 17  Comment 
The pharmaceutical industry's long-anticipated consolidation of CAR-T biotech companies may be starting.
Motley Fool  Jan 12  Comment 
This promising gene therapy company has some big catalysts coming.
Motley Fool  Jan 2  Comment 
CAR-T ruled the year, but don't forget about its gene therapy program.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki